Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

$PRCT Stock Loss: PROCEPT BioRobotics May Have Misrepresented its Revenue to Investors - Contact BFA Law About The Pending Securities Fraud Class Action

$PRCTPress releaseAug 1, 2026, 7:07 AM ETRead the release

Bleichmar Fonti & Auld LLP announced a class action lawsuit against PROCEPT BioRobotics alleging securities fraud related to misrepresented handpiece sales and discount programs. The complaint cites stock drops of 16%, 10%, and 18% in 2025 and 2026 following disclosures of excess inventory and contracting unit sales.

Key figures

Excess inventory units
> 10,000
Lead plaintiff deadline
September 22, 2026
Stock drop aug 2025 pct
16
Stock drop feb 2026 pct
18
Stock drop nov 2025 pct
10
Guidance reduction units
1000
Us handpiece sales decline pct
30%

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.